How BPC-157 Accelerates Tissue Regeneration and Healing
concentrations above 30mg/mL increase aggregation risk, while dilutions below 5mg/mL accelerate oxidative degradation
It works as an antioxidant through a conversion process to L-Cysteine to help neutralize toxins
As of April 22, 2026, it was removed from FDA Category 2, but the FDA's Pharmacy Compounding Advisory Committee will not consider it for the 503A bulks list until the July 23, 2026 meeting
Your provider or nurse walks you through the process step by step proper technique, injection site rotation, storage requirements, and whats normal at the injection site afterward
By bypassing the digestive system, the nutrients are absorbed more quickly and efficiently, allowing for faster results